Indaptus Therapeutics, Inc.INDPNASDAQ
Loading
Asset Growth Under PressureDecelerating
Percentile Rank74
5Y CAGR-74.0%
Year-over-Year Change
Year-over-year total asset growth rate
5Y CAGR
-74.0%/yr
Long-term compound
Percentile
P74
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | 0.01% |
| Q2 2025 | 26.38% |
| Q1 2025 | -26.26% |
| Q4 2024 | -10.94% |
| Q3 2024 | 1.45% |
| Q2 2024 | -25.82% |
| Q1 2024 | -26.64% |
| Q4 2023 | -16.13% |
| Q3 2023 | -14.64% |
| Q2 2023 | -9.94% |
| Q1 2023 | -17.53% |
| Q4 2022 | -7.85% |
| Q3 2022 | -10.59% |
| Q2 2022 | -8.16% |
| Q1 2022 | -8.60% |
| Q4 2021 | -7.48% |
| Q3 2021 | 118.29% |
| Q2 2021 | 276.12% |
| Q1 2021 | 200.48% |
| Q4 2020 | -92.60% |
| Q3 2020 | 10.34% |
| Q2 2020 | 5.56% |
| Q1 2020 | -3.03% |
| Q4 2019 | -30.87% |
| Q3 2019 | -34.31% |
| Q2 2019 | -17.23% |
| Q1 2019 | -7.96% |
| Q4 2018 | -13.97% |
| Q3 2018 | -13.86% |
| Q2 2018 | 53.28% |
| Q1 2018 | -16.11% |
| Q4 2017 | -10.41% |
| Q3 2017 | 192.67% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2015 | -8.52% |
| Q3 2015 | 233.02% |
| Q2 2015 | 0.00% |
| Q1 2015 | 0.00% |